In vitro analysis shows salvianolic acid B inhibits melanoma cell proliferation and glycolysis, indicating a potential therapeutic approach.
Sal B suppressed the viability and abnormal glycolysis of melanoma cells by mediating PKM2 expression.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: